Piper Sandler对Replimune Group Inc.(股票代码:REPL)的评级进行了显著调整。这家投行将该公司股票评级从“中性”一举上调至“增持”,与此同时,其目标价也从之前的9美元大幅提高至14美元。
Piper Sandler对Replimune Group Inc.(股票代码:REPL)的评级进行了显著调整。这家投行将该公司股票评级从“中性”一举上调至“增持”,与此同时,其目标价也从之前的9美元大幅提高至14美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.